Amendment No. 1 to the Manufacturing Agreement Between The American National Red Cross, Penn-Jersey Region (“ARC”), and Macrocure Ltd. (“Macrocure”)Macrocure Ltd. • June 18th, 2014 • Biological products, (no disgnostic substances)
WHEREAS, ARC and Macrocure entered into the Non Clinical and Clinical Manufacturing Agreement, dated July 11, 2010 (the “Manufacturing Agreement”); and
MANUFACTURING AGREEMENTManufacturing Agreement • June 18th, 2014 • Macrocure Ltd. • Biological products, (no disgnostic substances) • London
This MANUFACTURING AGREEMENT (the “Agreement”), dated as of 26th February, 2014 (the “Execution Date”), is entered into between Maco Productions, a corporation organized under the laws of France, registered at the Trade Register of Lille Métropole under n° 313 777 997 and Represented by Mr. Ronald de Lagrange-Chancel, President and Maco Pharma, a corporation organized under the laws of France, registered at the Trade Register of Lille Métropole under n° 391 600 905 and Represented by Mr. Ronald de Lagrange-Chancel, President (hereinafter called together the “Contractor”), and Macrocure LTD., a corporation organized under the laws of Israel with a principal place of business at 25 Hasivim St. Petach Tikva 49517, Israel (hereinafter called the “Customer”).
SOURCE LEUKOCYTES AND PLASMA AGREEMENT FOR TRANSFUSIBLE BLOOD PRODUCTS FOR IN VIVO HUMAN SUBJECT RESEARCH USESource Leukocytes and Plasma Services Agreement • June 18th, 2014 • Macrocure Ltd. • Biological products, (no disgnostic substances) • Pennsylvania
THIS SOURCE LEUKOCYTES AND PLASMA SERVICES AGREEMENT (“Agreement”) is entered into as of the Effective Date (as defined below) by and between The American National Red Cross, Penn-Jersey Blood Services Region (“ARC”), a non-profit corporation with offices located at 700 Spring Garden Street, Philadelphia, PA 19123 and Macrocure Ltd. (“Customer”), a company incorporated under the laws of the State of Israel with a place of business at 9 Bareket Street, Kiryat Matalon, Petach Tikva 49205, Israel.
NON CLINICAL AND CLINICAL MANUFACTURING AGREEMENTNon Clinical and Clinical Manufacturing Agreement • June 18th, 2014 • Macrocure Ltd. • Biological products, (no disgnostic substances) • New York
MacroCure Ltd., a company incorporated under the laws of the State of Israel with a place of business 9 Bareket Street, Kiryat Matalon, Petach Tikva 49205, Israel), hereinafter referred to as “MacroCure”.
FIRST AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 18th, 2014 • Macrocure Ltd. • Biological products, (no disgnostic substances)
THIS AGREEMENT is made as of the 3 day of May, 2012 by and among Macrocure Ltd., an Israeli company (the “Company”), and the holders of Series A Preferred Shares, as listed in Schedule A hereto (the “Investors”).
Amendment No. 1 to the Source Leukocytes and Plasma Agreement Between The American National Red Cross, Penn-Jersey Region (“ARC”), and Macrocure Ltd. (“Macrocure”)Macrocure Ltd. • June 18th, 2014 • Biological products, (no disgnostic substances)
WHEREAS, ARC and Macrocure entered into the Source Leukocytes and Plasma Agreement with an ARC execution date of March 26, 2013 (the “Agreement”); and
